Skip to main content
SpringerLink
Log in

Rofecoxib introduction in Italy affects prescribing, costs in OA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rofecoxib introduction in Italy affects prescribing, costs in OA. Pharmacoecon. Outcomes News 422, 5 (2003). https://doi.org/10.1007/BF03276547

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03276547

Keywords

Search

Navigation